Prognostic value of body composition in patients with digestive tract cancers: A prospective cohort study of 8,267 adults from China
View abstract on PubMed
Summary
This summary is machine-generated.A large skeletal muscle area indicates a better prognosis for digestive tract cancer patients. Conversely, cancer cachexia and sarcopenia are linked to a poorer outlook, guiding personalized preoperative assessments.
Area Of Science
- Oncology
- Radiology
- Body Composition Analysis
Background
- Prognostic value of body composition in digestive tract cancers is not fully understood.
- Computed tomography (CT) derived parameters require further characterization.
Purpose Of The Study
- To investigate the prognostic value of body composition parameters and phenotypes in patients with digestive tract cancers.
- To correlate body composition with clinical outcomes.
Main Methods
- Prospective cohort study of 8267 patients with digestive tract cancers.
- CT scans used to quantify skeletal muscle (SM), subcutaneous adipose tissue (SAT), and visceral adipose tissue (VAT) areas.
- Phenotypes including sarcopenia, cancer cachexia, and sarcopenic obesity were determined; overall survival analyzed using Kaplan-Meier and Cox proportional hazards models.
Main Results
- Larger SM area showed a favorable prognosis (lower mortality risk).
- Sarcopenia and cancer cachexia were associated with significantly poorer overall survival, particularly in male patients.
- Prognostic value varied across different digestive tract cancer types.
Conclusions
- Increased skeletal muscle area is a favorable prognostic indicator in digestive tract cancers.
- Cancer cachexia and sarcopenia are indicators of poor prognosis.
- Body composition assessment offers valuable insights for personalized preoperative risk stratification.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

